Company Monitoring Page for Enanta

latest headlines for company on cafepharma

Enanta's NASH drug barely meets main goal in mid-stage study
Endpoints
Thu, 09/26/19 - 10:59 am
Tags:
Enanta, NASH, clinical trials, EDP-305
AbbVie, Enanta post stellar hep C PhIII data, but no one is cheering
Endpoints
Thu, 04/20/17 - 08:52 pm
Tags:
AbbVie, Enanta, hepatitis C, glecaprevir/pibrentasvir
Enanta, among Boston's few profitable biotechs, earns another $30M
Bizjournals.com
Mon, 09/28/15 - 08:41 am
Tags:
Enanta, AbbVie, hepatitis C, Viekirax
Cubist, Enanta and Vertex still await FDA approval decisions this year
Bizjournals.com
Fri, 12/19/14 - 04:11 pm
Tags:
Cubist, Enanta, Vertex Pharmaceuticals, FDA, Zerbaxa, ABT-450, Kalydeco
Can Partnering To Fight Hepatitis C Pay At Enanta?
Investors.com
Mon, 11/24/14 - 06:23 pm
Tags:
hepatitis C, Enanta, paritaprevir
Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
Motley Fool
Fri, 11/7/14 - 10:11 am
Tags:
AbbVie, Gilead Sciences, Enanta, Harvoni, hepatitis C
[video]Biotech Losers: InterMune, Enanta, and GW Pharmaceuticals
Motley Fool
Fri, 02/7/14 - 10:49 am
Tags:
InterMune, GW Pharma, Enanta
Enanta Joins Big Leagues With Hepatitis C Drug
Investors.com
Wed, 01/8/14 - 08:07 am
Tags:
Enanta, hepatitis C, AbbVie, ABT-450, protease inhibitors
Why Enanta Pharmaceuticals Shares Sank Like a Stone
Motley Fool
Thu, 12/19/13 - 08:08 am
Tags:
Enanta, Sovaldi, Gilead Sciences, hepatitis C, ABT-450, AbbVie
A Chart You Should See: Biotech IPO Class of 2013 Is Lagging
TheStreet.com
Tue, 11/26/13 - 10:33 am
Tags:
IPOs, Bluebird Bio, Enanta, Portola Pharmaceuticals, Prosensa
2 Biotech Stocks Rising on Big Volume
TheStreet.com
Tue, 11/26/13 - 09:02 am
Tags:
Anika, Enanta
Upcoming Catalysts Should Provide Strong Upside For These BioPharma Companies
Seeking Alpha
Fri, 10/18/13 - 10:51 am
Tags:
Celldex, ImmunoCellular Therapeutics, Enanta, Merrimack Pharmaceuticals, Vanda
3 Humongous Health-Care Stocks This Week
Motley Fool
Sun, 09/22/13 - 11:08 am
Tags:
Omeros, Enanta, AbbVie
3 Biotechs With Recent Intensive Insider Buying
Seeking Alpha
Sun, 04/7/13 - 10:52 am
Tags:
Tetraphase Pharmaceuticals, Enanta, Inovio
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Wed, 07/11/12 - 12:12 pm
Tags:
Xenon, Virobay, Tolero Pharmaceuticals, Threshold Pharmaceuticals, Novartis, Merck KGaA, Merck, MannKind, licensing, Janssen, Isis Pharmaceuticals, Ironwood, Inhibrx Thrombogenics, GSK, Genmab, Genentech, Galapagos, Forma Therapeutics, Endocyte, Endo, Enanta, Celgene, Bristol-Myers Squibb, Boehringer Ingelheim, Bionomics, Biogen Idec, BioDelivery Sciences, AstraZeneca, Angiochem, AC Immune, Abbott Laboratories, LEO Pharma
Hepatitis C Remains A Hot Play
Seeking Alpha
Mon, 02/27/12 - 12:01 pm
Tags:
hepatitis C, Bristol-Myers Squibb, Novartis, Gilead, Inhibitex, Merck, Vertex, Pharmasset, Enanta
Enanta partners with Novartis to develop new drug to treat hepatitis C virus
Boston Globe, MA
Tue, 02/21/12 - 09:36 am
Tags:
Novartis, Enanta, hepatitis C, EDP-239
Abbott and Enanta begin hepatitis C trials
Hays Pharma, UK
Thu, 02/19/09 - 08:37 am
Tags:
Enanta, hepatitis C, Abbott Laboratories, drug trials

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.